Stuttgart - Delayed Quote EUR
Novavax Inc (NVV1.SG)
5.28
-0.82
(-13.43%)
At close: May 9 at 9:32:44 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-87,263
-87,263
-713,967
-415,937
322,946
Investing Cash Flow
-204,038
-204,038
-58,806
-92,985
100,154
Financing Cash Flow
260,583
260,583
4,466
324,988
461,713
End Cash Position
545,292
545,292
583,810
1,348,845
1,528,259
Income Tax Paid Supplemental Data
949
949
190
17,980
12,606
Interest Paid Supplemental Data
17,572
17,572
17,349
18,035
19,428
Capital Expenditure
-14,639
-14,639
-58,806
-92,985
-57,486
Issuance of Capital Stock
263,272
263,272
360,243
249,230
564,859
Issuance of Debt
0
0
0
175,250
0
Repayment of Debt
-3,994
-3,994
-352,345
-93,595
-127,907
Free Cash Flow
-101,902
-101,902
-772,773
-508,922
265,460
12/31/2021 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
22UA.BE BioNTech SE
85.25
+0.41%
BNTX.VI BioNTech SE
83.20
-0.42%
22UA.MU BioNTech SE
84.85
+0.83%
22UA.DU BioNTech SE
82.90
-2.36%
0QF.DE Moderna, Inc.
22.09
+2.63%
22UA.DE BioNTech SE
83.35
-0.71%
RAPT RAPT Therapeutics, Inc.
0.7535
-5.81%
ZBIO Zenas BioPharma, Inc.
9.05
-2.58%
IPA ImmunoPrecise Antibodies Ltd.
0.4489
-1.88%
ACRS Aclaris Therapeutics, Inc.
1.2600
-3.82%